Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 34

Results For "2022"

1420 News Found

Astec LifeSciences posts consolidated Q1FY24 loss at Rs. 8.19 Cr
News | July 28, 2023

Astec LifeSciences posts consolidated Q1FY24 loss at Rs. 8.19 Cr

Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023


Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
News | July 28, 2023

Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr

The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023


Dr. Lal Path Labs Q1FY24 consolidated PAT up at Rs. 82.6 Cr
News | July 28, 2023

Dr. Lal Path Labs Q1FY24 consolidated PAT up at Rs. 82.6 Cr

Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023


Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr
News | July 28, 2023

Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr

The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023


Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr
News | July 27, 2023

Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr

Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023


Teva Pharmaceuticals engages Honeywell to help reduce carbon impact
Sustainability | July 26, 2023

Teva Pharmaceuticals engages Honeywell to help reduce carbon impact

Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model


Robotic surgery enhances success rate in knee replacements
Healthcare | July 26, 2023

Robotic surgery enhances success rate in knee replacements

Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%


NATCO files generic Erdafitinib Tablets in USA
Drug Approval | July 26, 2023

NATCO files generic Erdafitinib Tablets in USA

Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma


Jubilant Ingrevia consolidated Q1 FY2024 PAT up QoQ at Rs. 57.59 Cr
News | July 26, 2023

Jubilant Ingrevia consolidated Q1 FY2024 PAT up QoQ at Rs. 57.59 Cr

Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023


Apollo performs 23000+ multi-organ transplantation
Healthcare | July 24, 2023

Apollo performs 23000+ multi-organ transplantation

Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants